enGene Holdings updates corporate presentation; no specific operational or financial changes disclosed

enGene Therapeutics Inc.

Corporate presentation dated September 5, 2024 furnished as Exhibit 99.1.
Presentation titled 'Non-Viral Genetic Medicine' — no new pipeline or financial data provided in this filing.
No material events such as earnings, leadership changes, or financing announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.